Who Supplies Efavirenz? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Efavirenz exports, with 101+ registered manufacturers shipping to buyers across 121+ countries — yet a handful of companies dominate the shipments. MACLEODS PHARMACEUTICALS LTD holds the largest share at 29.6% (export value: $17.8M). Close behind, MYLAN LABORATORIES LIMITED (28.0%, $16.9M). CIPLA LIMITED (7.8%, $4.7M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.

🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Efavirenz? Top Manufacturers & Their Buyers
Flow of Efavirenz from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Efavirenz Supplier Network — Key Market Intelligence
The Efavirenz export market from India is led by MACLEODS PHARMACEUTICALS LTD, which alone commands a 29.6% share, shipping $17.8M worth of product across 121 shipments. The second-largest exporter, MYLAN LABORATORIES LIMITED, contributes $16.9M (28.0%) to the overall market. Combined, the top two suppliers alone account for 57.6% of all Efavirenz exports, indicating a relatively concentrated supply base.
Across all 101 tracked manufacturers, the total Efavirenz export value stands at $60.2M from 1.1K shipments. The market average shipment value is $55.5K. The single largest buyer relationship in terms of trade value is VIATRIS HEALTHCARE (PTY) LTD,, receiving $13.6M worth of product.
The combined buyer network spans 19 named purchasing companies, including MACLEODS PHARMACEUTICALS SA (PTY), GLENMARK PHARMACEUTICALS S R O, ICU VITA, NATIONAL CENTER FOR DISEASE CONTROL, SYNOPTIS INDUSTRIAL SP .ZO.O and 14 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1MACLEODS PHARMACEUTICALS LTD
MACLEODS PHARMACEUTICALS LTD is the first-largest Efavirenz exporter from India, with a market share of 29.6% and a total export value of $17.8M across 121 shipments. Their average shipment value of $147.1K is above the market average of $55.5K, suggesting premium or bulk contract pricing.
MACLEODS PHARMACEUTICALS LTD serves 5 named buyers in our database. MACLEODS PHARMACEUTICALS SA (PTY) is the dominant customer, accounting for 63.3% of this supplier's tracked business. Top customers include:
• MACLEODS PHARMACEUTICALS SA (PTY) — $11.3M across 77 shipments (63.3% of this supplier's total exports)
• GLENMARK PHARMACEUTICALS S R O — $3.6M across 25 shipments (20.3% of this supplier's total exports)
• ICU VITA — $2.1M across 14 shipments (11.6% of this supplier's total exports)
• NATIONAL CENTER FOR DISEASE CONTROL — $517.8K across 4 shipments (2.9% of this supplier's total exports)
• SYNOPTIS INDUSTRIAL SP .ZO.O — $342.4K across 2 shipments (1.9% of this supplier's total exports)
Key Insight: MACLEODS PHARMACEUTICALS LTD's per-shipment value of $147.1K is 165% above the market average of $55.5K, consistent with large-order contracts or value-added formulations.
2MYLAN LABORATORIES LIMITED
MYLAN LABORATORIES LIMITED is the second-largest Efavirenz exporter from India, with a market share of 28.0% and a total export value of $16.9M across 167 shipments. Their average shipment value of $101.0K is above the market average of $55.5K, suggesting premium or bulk contract pricing.
MYLAN LABORATORIES LIMITED serves 5 named buyers in our database. VIATRIS HEALTHCARE (PTY) LTD, is the dominant customer, accounting for 80.7% of this supplier's tracked business. Top customers include:
• VIATRIS HEALTHCARE (PTY) LTD, — $13.6M across 135 shipments (80.7% of this supplier's total exports)
• PAHANG PHARMACY SDN BHD — $1.2M across 12 shipments (7.0% of this supplier's total exports)
• PAHANG PHARMACY SDN BHD — $1.1M across 11 shipments (6.6% of this supplier's total exports)
• VIATRIS HEALTHCARE PTY LIMITED — $702.8K across 7 shipments (4.2% of this supplier's total exports)
• CENTRAL MEDICAL STOR — $265.0K across 3 shipments (1.6% of this supplier's total exports)
Key Insight: MYLAN LABORATORIES LIMITED's per-shipment value of $101.0K is 82% above the market average of $55.5K, consistent with large-order contracts or value-added formulations.
3CIPLA LIMITED
CIPLA LIMITED is the third-largest Efavirenz exporter from India, with a market share of 7.8% and a total export value of $4.7M across 59 shipments. Their average shipment value of $79.2K is above the market average of $55.5K, suggesting premium or bulk contract pricing.
CIPLA LIMITED serves 5 named buyers in our database. STATE ENTERPRISE ACADEMPHARM is the dominant customer, accounting for 84.7% of this supplier's tracked business. Top customers include:
• STATE ENTERPRISE ACADEMPHARM — $4.0M across 50 shipments (84.7% of this supplier's total exports)
• CIPLA COLOMBIA SAS Y/O DEPOSITO UPS — $246.0K across 3 shipments (5.3% of this supplier's total exports)
• PHARMACIE CENTRALE D — $173.7K across 2 shipments (3.7% of this supplier's total exports)
• PHARMACIE CENTRALE D — $147.1K across 2 shipments (3.1% of this supplier's total exports)
• CIPLA COLOMBIA SAS Y/O DEPOSITO UPS — $145.7K across 2 shipments (3.1% of this supplier's total exports)
Key Insight: CIPLA LIMITED's per-shipment value of $79.2K is 43% above the market average of $55.5K, consistent with large-order contracts or value-added formulations.
4MACLEODS PHARMACEUTICALS LIMITED
MACLEODS PHARMACEUTICALS LIMITED is the fourth-largest Efavirenz exporter from India, with a market share of 3.9% and a total export value of $2.3M across 56 shipments. Their average shipment value of $41.9K is below the market average of $55.5K, reflecting a high-volume, competitive pricing strategy.
MACLEODS PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• NATIONAL EMERGENCY RESPONSE COUNCIL HIV — $1.0M across 25 shipments (44.3% of this supplier's total exports)
• MACLEODS PHARMACEUTICALS SA (PTY) — $601.0K across 14 shipments (25.6% of this supplier's total exports)
• GLENMARK PHARMACEUTICALS S R O — $390.3K across 9 shipments (16.6% of this supplier's total exports)
• ALSTONS MARKETING CO — $166.7K across 4 shipments (7.1% of this supplier's total exports)
• GLENMARK PHARMACEUTICALS S R O — $150.7K across 4 shipments (6.4% of this supplier's total exports)
Key Insight: MACLEODS PHARMACEUTICALS LIMITED operates with high shipment frequency (56 shipments) at a per-shipment value of $41.9K, indicating a broad distribution network with many smaller, regular orders.
5HETERO LABS LIMITED
HETERO LABS LIMITED is the fifth-largest Efavirenz exporter from India, with a market share of 1.7% and a total export value of $1.0M across 49 shipments. Their average shipment value of $21.4K is below the market average of $55.5K, reflecting a high-volume, competitive pricing strategy.
HETERO LABS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• TO THE ORDER OF — $324.2K across 15 shipments (30.9% of this supplier's total exports)
• M S TO THE ORDER OF — $212.2K across 10 shipments (20.2% of this supplier's total exports)
• XXN AXXRICXX HEXXTH — $203.7K across 10 shipments (19.4% of this supplier's total exports)
• XXN AXXRICXX HEXXTH — $203.5K across 10 shipments (19.4% of this supplier's total exports)
• TO THE ORDER — $105.5K across 5 shipments (10.1% of this supplier's total exports)
Key Insight: HETERO LABS LIMITED operates with high shipment frequency (49 shipments) at a per-shipment value of $21.4K, indicating a broad distribution network with many smaller, regular orders.
6MICRO LABS LIMITED
MICRO LABS LIMITED is the fifth-largest Efavirenz exporter from India, with a market share of 1.4% and a total export value of $849.5K across 55 shipments. Their average shipment value of $15.4K is below the market average of $55.5K, reflecting a high-volume, competitive pricing strategy.
MICRO LABS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• DIGECITSS-MINISTERIO DE SALUD — $260.0K across 17 shipments (30.6% of this supplier's total exports)
• UNOPS MYANMAR OC — $230.2K across 15 shipments (27.1% of this supplier's total exports)
• ETHIOPIAN PHARMACEUT — $171.6K across 11 shipments (20.2% of this supplier's total exports)
• UNOPS MYANMAR OC — $101.6K across 7 shipments (12.0% of this supplier's total exports)
• RWANDA MEDICAL SUPPL — $86.2K across 6 shipments (10.1% of this supplier's total exports)
Key Insight: MICRO LABS LIMITED operates with high shipment frequency (55 shipments) at a per-shipment value of $15.4K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Efavirenz Flows
Once Efavirenz leaves the manufacturing plants of companies like MACLEODS PHARMACEUTICALS LTD and MYLAN LABORATORIES LIMITED, it travels to 5 destination markets with a combined import value of $60.2M. South Africa absorbs the largest share at 49.2% ($29.6M), followed by Belarus (7.1%) and United Kingdom (6.9%).
In South Africa — the top destination — named importers include VIATRIS HEALTHCARE (PTY) LTD,, MACLEODS PHARMACEUTICALS SA, NATIONAL EMERGENCY RESPONSE COUNCIL HIV. In Belarus, key buyers are STATE ENTERPRISE ACADEMPHARM.
This geographic spread reflects Efavirenz's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Efavirenz Go? Top Importing Countries & Their Buyers
Trade flow of Efavirenz exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1South Africa
South Africa ranks as the first-largest destination for Efavirenz imports from India, with a total trade value of $29.6M across 41 shipments — representing a 49.2% share of all Efavirenz exports. The average shipment value of $721.8K is above the global average of $55.5K, indicating high-value procurement contracts or branded formulations. This market is served by 5 tracked buyers.
Named Efavirenz importers in South Africa: VIATRIS HEALTHCARE (PTY) LTD, is the largest buyer, accounting for 47.8% ($14.1M) of this market's total imports.
• VIATRIS HEALTHCARE (PTY) LTD, — $14.1M (47.8% of South Africa's total)
• MACLEODS PHARMACEUTICALS SA — $12.2M (41.4% of South Africa's total)
• NATIONAL EMERGENCY RESPONSE COUNCIL HIV — $1.0M (3.5% of South Africa's total)
Key Insight: South Africa's per-shipment average of $721.8K (1200% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
South Africa is a key market for Efavirenz imports from India.
2Belarus
Belarus ranks as the second-largest destination for Efavirenz imports from India, with a total trade value of $4.3M across 3 shipments — representing a 7.1% share of all Efavirenz exports. The average shipment value of $1.4M is above the global average of $55.5K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Efavirenz importers in Belarus: STATE ENTERPRISE ACADEMPHARM is the largest buyer, accounting for 92.4% ($4.0M) of this market's total imports.
• STATE ENTERPRISE ACADEMPHARM — $4.0M (92.4% of Belarus's total)
Key Insight: Belarus's per-shipment average of $1.4M (2471% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Belarus is a key market for Efavirenz imports from India.
3United Kingdom
United Kingdom ranks as the third-largest destination for Efavirenz imports from India, with a total trade value of $4.2M across 4 shipments — representing a 6.9% share of all Efavirenz exports. The average shipment value of $1.0M is above the global average of $55.5K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Efavirenz importers in United Kingdom: GLENMARK PHARMACEUTICALS EUROPE LTD is the largest buyer, accounting for 86.4% ($3.6M) of this market's total imports.
• GLENMARK PHARMACEUTICALS EUROPE LTD — $3.6M (86.4% of United Kingdom's total)
Key Insight: United Kingdom's per-shipment average of $1.0M (1781% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United Kingdom is a key market for Efavirenz imports from India.
4Malaysia
Malaysia ranks as the fourth-largest destination for Efavirenz imports from India, with a total trade value of $3.5M across 57 shipments — representing a 5.8% share of all Efavirenz exports. The average shipment value of $61.3K is above the global average of $55.5K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Efavirenz importers in Malaysia: PAHANG PHARMACY SDN BHD, is the largest buyer, accounting for 47.8% ($1.7M) of this market's total imports.
• PAHANG PHARMACY SDN BHD, — $1.7M (47.8% of Malaysia's total)
• PAHANG PHARMACY SDN BHD — $1.4M (41.4% of Malaysia's total)
Key Insight: Malaysia's per-shipment average of $61.3K (10% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Malaysia is a key market for Efavirenz imports from India.
5Uruguay
Uruguay ranks as the fifth-largest destination for Efavirenz imports from India, with a total trade value of $2.1M across 2 shipments — representing a 3.5% share of all Efavirenz exports. The average shipment value of $1.0M is above the global average of $55.5K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Efavirenz importers in Uruguay: ICU VITA is the largest buyer, accounting for 99.8% ($2.1M) of this market's total imports.
• ICU VITA — $2.1M (99.8% of Uruguay's total)
Key Insight: Uruguay's per-shipment average of $1.0M (1771% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Uruguay is a key market for Efavirenz imports from India.
People Also Ask — Efavirenz Supplier & Trade Network
Who are the top suppliers of Efavirenz from India?+
Which companies buy Efavirenz from Indian manufacturers?+
Where does Efavirenz exported from India go?+
What is the market share of the top Efavirenz supplier from India?+
What is the average shipment value for Efavirenz exports from India?+
Is Efavirenz manufactured in India and exported globally?+
Which country imports the most Efavirenz from India?+
Who are the buyers of Efavirenz in Belarus?+
How concentrated is the Efavirenz supplier market in India?+
How do I find verified buyers for Efavirenz in specific countries?+
Efavirenz Trade Network — Key Takeaways
- 1MACLEODS PHARMACEUTICALS LTD is India's dominant Efavirenz exporter with a 29.6% market share and $17.8M in total exports — making it the single most important sourcing entity in this market.
- 2The top 101 suppliers collectively account for 72.4% of all tracked Efavirenz exports, with a combined trade value of $60.2M.
- 3South Africa is the largest destination market, absorbing 49.2% of India's Efavirenz exports ($29.6M). Belarus (7.1%) and United Kingdom (6.9%) follow.
- 4With 1.1K total shipments averaging $55.5K each, the Efavirenz export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include MACLEODS PHARMACEUTICALS SA (PTY), GLENMARK PHARMACEUTICALS S R O, VIATRIS HEALTHCARE (PTY) LTD,, PAHANG PHARMACY SDN BHD — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 121 countries
Network value: $60.2M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Efavirenz — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Efavirenz.
- 2.Flow Mapping: 101 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 1,084 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 121 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1,084 Verified Shipments
101 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists